1. Abu-Farha M, Ghosh A, Al-Khairi I, Murthy Madiraju SR, Abubaker J, Prentki M. The multi-faces of Angptl8 in health and disease: Novel functions beyond lipoprotein lipase modulation. Prog Lipid Res 2020;80:101067.
https://doi.org/10.1016/j.plipres.2020.101067
4. Aron-Wisnewsky J, Warmbrunn MV, Nieuwdorp M, Clément K. Metabolism and metabolic disorders and the microbiome: the intestinal microbiota associated with obesity, lipid metabolism, and metabolic health-pathophysiology and therapeutic strategies. Gastroenterology 2021;160:573–99.
https://doi.org/10.1053/j.gastro.2020.10.057
13. Ruscica M, Zimetti F, Adorni MP, et al. Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemia. Pharmacol Res 2020;153:104653.
https://doi.org/10.1016/j.phrs.2020.104653
16. Chen YQ, Pottanat TG, Siegel RW, et al. Angiopoietin-like protein 4(E40K) and ANGPTL4/8 complex have reduced, temperature-dependent LPL-inhibitory activity compared to ANGPTL4. Biochem Biophys Res Commun 2021;534:498–503.
https://doi.org/10.1016/j.bbrc.2020.11.053
32. Yan H, Zhou P, Zhang Y, Zhang Z, Liu J, Zhang H. Short-chain fructo-oligosaccharides alleviates oxidized oil-induced intestinal dysfunction in piglets associated with the modulation of gut microbiota. J Funct Foods 2020;64:103661.
https://doi.org/10.1016/j.jff.2019.103661
35. Ono M, Shimizugawa T, Shimamura M, et al. Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3): ANGPTL3 is cleaved and activated in vivo. J Biol Chem 2003;278:41804–9.
https://doi.org/10.1074/jbc.M302861200
36. Feng SQ, Chen XD, Xia T, et al. Cloning, chromosome mapping and expression characteristics of porcine ANGPTL3 and -4. Cytogenet Genome Res 2006;114:44–9.
https://doi.org/10.1159/000091927
45. Miao ZG, Wang LJ, Xu ZR, Huang JF, Wang YR. Developmental changes of carcass composition, meat quality and organs in the Jinhua pig and Landrace. Animal 2009;3:468–73.
https://doi.org/10.1017/S1751731108003613